Results: 1-25 | 26-50 | 51-72
Results: 1-25/72
ACE-INHIBITORS, ANGIOTENSIN-II ANTAGONISTS AND COUGH
Authors: RAMSAY LE YEO WW
Citation: Le. Ramsay et Ww. Yeo, ACE-INHIBITORS, ANGIOTENSIN-II ANTAGONISTS AND COUGH, Journal of human hypertension, 9, 1995, pp. 51-54
ACE-INHIBITORS, COUGH, AND GENETICS
Authors: CHADWICK IG YEO WW HIGGINS KS JACKSON PR RAMSAY LE MORICE AH
Citation: Ig. Chadwick et al., ACE-INHIBITORS, COUGH, AND GENETICS, Lancet, 343(8899), 1994, pp. 740-741
A COMPARISON OF COUGH IN HYPERTENSIVE PATIENTS RECEIVING TELMISARTAN,ENALAPRIL, OR HYDROCHLOROTHIAZIDE
Authors: RAMSAY LE KIRWAN BA
Citation: Le. Ramsay et Ba. Kirwan, A COMPARISON OF COUGH IN HYPERTENSIVE PATIENTS RECEIVING TELMISARTAN,ENALAPRIL, OR HYDROCHLOROTHIAZIDE, Journal of hypertension, 16, 1998, pp. 31053-31053
ACUTE-RENAL-FAILURE WITH ACE-INHIBITION IN AORTIC COARCTATION
Authors: WOODMANSEY PA YEO WW JACKSON PR RAMSAY LE
Citation: Pa. Woodmansey et al., ACUTE-RENAL-FAILURE WITH ACE-INHIBITION IN AORTIC COARCTATION, Postgraduate medical journal, 70(830), 1994, pp. 927-929
AMERICAN-COLLEGE OF PHYSICIANS GUIDELINES ON CHOLESTEROL SCREENING
Authors: HAQ IU JACKSON PR RAMSAY LE
Citation: Iu. Haq et al., AMERICAN-COLLEGE OF PHYSICIANS GUIDELINES ON CHOLESTEROL SCREENING, Annals of internal medicine, 125(12), 1996, pp. 1010-1010
BRIDGING THE GAP BETWEEN CLINICAL-PHARMACOLOGY AND RATIONAL DRUG PRESCRIBING
Authors: RAMSAY LE
Citation: Le. Ramsay, BRIDGING THE GAP BETWEEN CLINICAL-PHARMACOLOGY AND RATIONAL DRUG PRESCRIBING, British journal of clinical pharmacology, 35(6), 1993, pp. 575-576
CARDIOVASCULAR-DISEASE - WARFARIN IN CHRONIC ATRIAL-FIBRILLATION
Authors: RAMSAY LE
Citation: Le. Ramsay, CARDIOVASCULAR-DISEASE - WARFARIN IN CHRONIC ATRIAL-FIBRILLATION, Lancet, 341(8857), 1993, pp. 1376-1377
CHOLESTANOL AND SURVIVAL WITH SIMVASTATIN - MORE DATA ARE NEEDED
Authors: WALLIS EJ WILLIAMSON R RAMSAY LE YEO WW JACKSON PR
Citation: Ej. Wallis et al., CHOLESTANOL AND SURVIVAL WITH SIMVASTATIN - MORE DATA ARE NEEDED, BMJ. British medical journal, 317(7167), 1998, pp. 1252-1252
CHOLESTEROL AND PREVENTION OF CORONARY HEART-DISEASE
Authors: HAQ IU JACKSON PR YEO WW RAMSAY LE
Citation: Iu. Haq et al., CHOLESTEROL AND PREVENTION OF CORONARY HEART-DISEASE, Lancet, 349(9046), 1997, pp. 210-211
CLINICAL-PHARMACOLOGY WITH CONFIDENCE
Authors: WALLER PC JACKSON PR TUCKER GT RAMSAY LE
Citation: Pc. Waller et al., CLINICAL-PHARMACOLOGY WITH CONFIDENCE, British journal of clinical pharmacology, 37(4), 1994, pp. 309-310
COMBINED INHIBITION OF NEUTRAL ENDOPEPTIDASE AND ANGIOTENSIN-CONVERTING ENZYME BY SAMPATRILAT IN ESSENTIAL-HYPERTENSION
Authors: WALLIS EJ RAMSAY LE HETTIARACHCHI J
Citation: Ej. Wallis et al., COMBINED INHIBITION OF NEUTRAL ENDOPEPTIDASE AND ANGIOTENSIN-CONVERTING ENZYME BY SAMPATRILAT IN ESSENTIAL-HYPERTENSION, Clinical pharmacology and therapeutics, 64(4), 1998, pp. 439-449
COMBINED LISINOPRIL AND HYDROCHLOROTHIAZIDE IN HYPERTENSION MANAGEMENT
Authors: RAMSAY LE
Citation: Le. Ramsay, COMBINED LISINOPRIL AND HYDROCHLOROTHIAZIDE IN HYPERTENSION MANAGEMENT, Drug development research, 1995, pp. 1-2
CURRENT RECOMMENDATIONS FOR INITIAL THERAPY IN HYPERTENSION - ARE THEY STILL VALID - DISCUSSION
Authors: MOSER M RAMSAY LE ELLIOTT WJ WEBER MA BLACK H ROCCELLA E
Citation: M. Moser et al., CURRENT RECOMMENDATIONS FOR INITIAL THERAPY IN HYPERTENSION - ARE THEY STILL VALID - DISCUSSION, American journal of hypertension, 11(6), 1998, pp. 95-100
CYTOCHROMES P450 MEDIATING THE N-DEMETHYLATION OF AMITRIPTYLINE
Authors: GHAHRAMANI P ELLIS SW LENNARD MS RAMSAY LE TUCKER GT
Citation: P. Ghahramani et al., CYTOCHROMES P450 MEDIATING THE N-DEMETHYLATION OF AMITRIPTYLINE, British journal of clinical pharmacology, 43(2), 1997, pp. 137-144
DIETARY-TREATMENT OF HYPERLIPEMIA - DIETS WERE POORLY EVALUATED
Authors: RAMSAY LE YEO WW JACKSON PR
Citation: Le. Ramsay et al., DIETARY-TREATMENT OF HYPERLIPEMIA - DIETS WERE POORLY EVALUATED, BMJ. British medical journal, 308(6933), 1994, pp. 916-916
DOES CHOLESTEROL REDUCTION LOWER BLOOD-PRESSURE
Authors: WALLIS EJ HAQ IU MINNIS R PALMER R GHARAMANI P YEO W JACKSON PR RAMSAY LE
Citation: Ej. Wallis et al., DOES CHOLESTEROL REDUCTION LOWER BLOOD-PRESSURE, Hypertension, 32(4), 1998, pp. 1-1
DOES WHITE-COAT EFFECT CONTRIBUTE TO TREATMENT RESISTANCE IN HYPERTENSION
Authors: DAVIES SJC GHAHRAMANI P PALMER RL HIPPISLEYCOX J JACKSON PR YEO WW RAMSAY LE
Citation: Sjc. Davies et al., DOES WHITE-COAT EFFECT CONTRIBUTE TO TREATMENT RESISTANCE IN HYPERTENSION, Journal of hypertension, 16, 1998, pp. 27073-27073
DOUBLE-BLIND COMPARISON OF LOSARTAN, LISINOPRIL AND HYDROCHLOROTHIAZIDE IN HYPERTENSIVE PATIENTS WITH A PREVIOUS ANGIOTENSIN-CONVERTING ENZYME INHIBITOR-ASSOCIATED COUGH
Authors: RAMSAY LE YEO WW
Citation: Le. Ramsay et Ww. Yeo, DOUBLE-BLIND COMPARISON OF LOSARTAN, LISINOPRIL AND HYDROCHLOROTHIAZIDE IN HYPERTENSIVE PATIENTS WITH A PREVIOUS ANGIOTENSIN-CONVERTING ENZYME INHIBITOR-ASSOCIATED COUGH, Journal of hypertension, 13, 1995, pp. 73-76
DRUG-THERAPY FOR CORONARY HEART-DISEASE - THE SHEFFIELD TABLE
Authors: WALLIS EJ RAMSAY LE JACKSON PR YEO WW WILLIAMSON R
Citation: Ej. Wallis et al., DRUG-THERAPY FOR CORONARY HEART-DISEASE - THE SHEFFIELD TABLE, Lancet, 350(9094), 1997, pp. 1852-1852
DRUG-THERAPY FOR CORONARY HEART-DISEASE - THE SHEFFIELD TABLE
Authors: RAMSAY LE WALLIS EJ HAQ IU YEO WW JACKSON PR
Citation: Le. Ramsay et al., DRUG-THERAPY FOR CORONARY HEART-DISEASE - THE SHEFFIELD TABLE, Lancet, 351(9100), 1998, pp. 443-443
EFFECT OF COFFEE AND CIGARETTE-SMOKING ON THE BLOOD-PRESSURE OF PATIENTS WITH ACCELERATED (MALIGNANT) HYPERTENSION
Authors: FREESTONE S YEO WW RAMSAY LE
Citation: S. Freestone et al., EFFECT OF COFFEE AND CIGARETTE-SMOKING ON THE BLOOD-PRESSURE OF PATIENTS WITH ACCELERATED (MALIGNANT) HYPERTENSION, Journal of human hypertension, 9(2), 1995, pp. 89-91
EFFECT OF CYP2D6 GENETIC-POLYMORPHISM ON SIDE-EFFECTS OF AMITRIPTYLINE AND NORTRIPTYLINE
Authors: GHAHRAMANI P DAVIES SJC YEO WW JACKSON PR TUCKER GT RAMSAY LE
Citation: P. Ghahramani et al., EFFECT OF CYP2D6 GENETIC-POLYMORPHISM ON SIDE-EFFECTS OF AMITRIPTYLINE AND NORTRIPTYLINE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 51-51
EFFECT OF DOSE ADJUSTMENT ON ENALAPRIL-INDUCED COUGH AND THE RESPONSETO INHALED CAPSAICIN
Authors: YEO WW HIGGINS KS FOSTER G JACKSON PR RAMSAY LE
Citation: Ww. Yeo et al., EFFECT OF DOSE ADJUSTMENT ON ENALAPRIL-INDUCED COUGH AND THE RESPONSETO INHALED CAPSAICIN, British journal of clinical pharmacology, 39(3), 1995, pp. 271-276
EFFECTS OF MODULATORS OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM ON COUGH
Authors: LACOURCIERE Y BRUNNER H IRWIN R KARLBERG BE RAMSAY LE SNAVELY DB DOBBINS TW FAISON EP NELSON EB CHRYSANT SG ISRAEL R IRWIN R POOL J RYAN WM SMALLWOOD K SYNHAVSKY A WAYNE J WINER N DIENSL F WEBB D GILCHRIST N KARLBERG BE SEGURA L BRUNNER HR HERRERA J MION D MALINI PL
Citation: Y. Lacourciere et al., EFFECTS OF MODULATORS OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM ON COUGH, Journal of hypertension, 12(12), 1994, pp. 1387-1393
FORCED HYPERVENTILATION INCREASES BLOOD-PRESSURE
Authors: CHADWICK IG TODD GPA RAMSAY LE
Citation: Ig. Chadwick et al., FORCED HYPERVENTILATION INCREASES BLOOD-PRESSURE, BMJ. British medical journal, 307(6907), 1993, pp. 803-804
Risultati: 1-25 | 26-50 | 51-72